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The speci®cation of neural fate in Xenopus embryos has been shown to be under regulation by negative factors. The
secreted protein bone morphogenetic protein-4 (BMP4) has been identi®ed as one of these factors: in the early gastrula
ectoderm, BMP4 can both inhibit neural fate and induce epidermis. In this study, we show that two other Xenopus BMP
genes, BMP2 and BMP7, are endowed with the same types of activities. First, we show that expression of a dominant
negative form of the BMP2 ligand, which blocks normal processing of the wild-type ligand, causes neuralization of Xenopus
ectoderm. Second, we have isolated the Xenopus BMP2/7 receptor (XALK2) and generated a constitutively active mutant
that signals in a ligand-independent manner. We show that signals from the activated BMP2/7 receptor also inhibit
neuralization and induce epidermis in dissociated ectoderm cells. Consistent with both ®ndings we show that secreted
BMP2 and BMP7 ligands can also mediate neural inhibition and epidermal induction. These results suggest that both
BMP2 and BMP7 may be involved independently or together with BMP4 in the inhibition of the neural fate and the onset
of the epidermal induction pathway in vivo. This further supports the idea that epidermal induction is due to the effects
of multiple signals from heterogeneous BMP genes. q 1997 Academic Press
INTRODUCTION nists that interfere with cell signaling at the cell-membrane
level, such as the truncated activin receptors (tAR) and the
truncated bone morphogenetic protein (BMP) receptor (tBR),The establishment of the central nervous system is a fun-
were shown to neuralize intact animal caps (Hemmati-Bri-damental event during development. Neural tissue in the
vanlou and Melton, 1994; Sasai et al., 1995; Suzuki et al.,Xenopus embryo was long thought to be induced by positive
1995; Xu et al., 1995). Activins and BMPs belong to thefactors derived from Spemann's organizer (Harland, 1994).
TGF-b superfamily of peptide growth factors. Third, experi-Recently, it has been proposed that neural fate is the default
ments performed with a dominant negative activin andfate for pluripotent ectodermal cells and that neuralization
BMP ligands suggested that BMPs are more likely candi-is due to the inhibition, rather than an activation, of a sig-
dates to ful®ll this biological function (Hawley et al., 1995).naling pathway (Hemmati-Brivanlou and Melton, 1997).
Fourth, BMP4, but not activin, was shown to both inhibit
This model is supported by several lines of evidence. First,
neuralization and induce epidermis in dissociated ectoder-
it was demonstrated that while intact early ectodermal ex- mal cells, providing the strongest evidence for the ``default
plants (animal caps) would differentiate as epidermis, disso- model'' of neuralization in Xenopus (Wilson and Hemmati-
ciation of ectoderm cells promoted neuralization (Grunz Brivanlou, 1995). In fact BMP4 remains to date the only
and Tacke, 1989; Godsave and Slack, 1991). Second, antago- epidermal inducer known in vertebrates. Fifth, consistent
with BMP4 acting as a neural inhibitor/epidermal inducer,
BMP4 transcripts are excluded from the organizer, and sub-1 Present address: Chugai Pharmaceutical Co., 135 Komakado, 1
sequently from the presumptive neural plate, and are en-chome, Gotemba-shi, Shizuoka 412, Japan.
riched in epidermal cells (Fainsod et al., 1994; Hemmati-2 Present address: Division of Morphogenesis, Department of
Brivanlou and Thomsen, 1995; Schmidt et al., 1995). Fi-Developmental Biology, National Institute for Basic Biology, Myo-
nally, three secreted organizer-speci®c factors with neuraldaiji, Okazaki 444, Japan.
inducing ability: noggin, follistatin, and chordin have been3 To whom correspondence should be addressed. Fax: 212-327-
8685. E-mail: brvnlou@rockvax.rockefeller.edu. recently characterized. While the case for follistatin is still
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Brivanlou, 1995). The dark outer cell layer was manually removedunder investigation, noggin and chordin have been shown
from the dissected caps and the inner layer of cells was dissociated.to bind directly to BMP4 and the consequence of this bind-
Dissociated cells were transferred into an agar-coated dish (1% ining is that BMP4 is denied access to its receptor (Piccolo et
water) containing 11 CMFB plus 0.5 mg/ml BSA with or withoutal., 1996; Zimmerman et al., 1996).
the addition of 50 ng/ml of recombinant human BMP4. After 5 hr,While many lines of evidence point to BMP4 as the endog-
cells were collected in Eppendorf tubes containing modi®ed 11
enous neural inhibitor and epidermal inducer, the issue of MBSH (15 mM Tris±HCl, pH 7.6, 110 mM NaCl, 2 mM KCl, 1
speci®city is not entirely solved. Is there something special mM MgSO4, 1 mM MgCl2, 1 mM CaCl2, 2 mM NaHCO3, 0.5 mM
about BMP4 or can other BMPs ful®ll the same type of sodium phosphate, 50 mg/ml gentamycin) by a brief centrifugation
activity? Although indirect, several lines of evidence from (70g) and allowed to reaggregate. Recombinant human BMP4 was
a gift from Genetics Institute, Inc.the literature seem to point to other BMPs as possible candi-
date epidermal inducers. For example, both noggin and
chordin bind BMP2 and BMP4 with similar af®nity, raising
Dominant Negative Mutant of Xenopus BMP2the possibility that inhibition of BMP2 might also be a re-
quirement for the unveiling of the neural fate (Piccolo et The Xenopus BMP2 gene (Nishimatsu et al., 1992) was cloned
al., 1996; Zimmerman et al., 1996). into pSP64TBX, a modi®ed vector of pSP64T (Krieg and Melton,
1984) which contains a polylinker sequence (BglII±NotI±SpeI±Follistatin has been shown to inhibit BMP7 function (Ya-
EcoRV±XhoI) in the original BglII site (a gift from M. Tada). PCR-mashita et al., 1995), although it is not clear if this inhibi-
based mutagenesis was performed as follows: separate PCR reac-tion involves direct binding to BMP7. Finally, as mentioned
tions were performed using two primer sets. Set A was SP6 primerabove, a dominant negative BMP7 ligand has been shown
(Promega) and an antisense oriented primer (5*-CCC TTG TTGto act as a neuralizer (Hawley et al., 1995). None of these
TCC TTT GTG AAG AGC ATG TCC-3*). Set B was a sense-ori-
studies, however, has addressed the epidermal inducing ented primer (5*-AAG GAC AAC AAG GGC AAG CTA GGC ACA
ability of other BMPs. AAC-3*) and 64T3*UTR primer (5*-GTA GCT TAG AGA CTC
Using a variety of approaches, we demonstrate that both CAT TCG-3*). PCR conditions were as follows: 947C, 1 min; 507C,
BMP2 and BMP7 act as neural inhibitors/epidermal in- 1 min; 727C, 2 min for 30 cycles. The two PCR products were
ducers. First, we have constructed a dominant negative mixed together and ampli®ed again using SP6 primer and
64T3*UTR primer using the same conditions. The ®nal PCR prod-BMP2 ligand and show that it induces neural tissue, at the
uct was subcloned into pSP64TBX and encodes the amino acidsexpense of epidermis, in intact animal caps. Second, we
``GQQG'' instead of ``RQKR'' at the processing site. This mutationhave isolated a Xenopus BMP2/7 receptor (XALK2), homolo-
in the nucleotide sequence was con®rmed by sequencing.gous to the mammalian ALK2, and have generated a consti-
tutively active form of this receptor (CA-XALK2) which
signals in a ligand-independent manner. The CA-XALK2 Isolation of Xenopus ALK2 Receptor and
induces epidermis in dissociated cells which would other- Mutagenesis
wise become neural. Finally, we show that mature BMP2
A partial clone of the Xenopus ALK2 receptor was isolated usingand BMP7 proteins can induce epidermis. These results fur-
PCR on Xenopus gastrula cDNA, as described previously (Suzukither support the idea that BMP2 and BMP7 as well as BMP4
et al., 1995). The sequence corresponded to the kinase subdomainsare involved in the epidermal induction pathway and that
VIII±XI of the receptor and showed 95% homology to human ALK2,
epidermal induction might be the result of signals from an activin-like kinase receptor, which binds activin, BMP7 (OP-1),
multiple members of the BMP subfamily of the TGF-b sig- and BMP2 (Attisano et al., 1993; Liu et al., 1995; ten Dijke et al.,
naling molecules. 1994a, b). A full-length cDNA of the XALK2 receptor was isolated
by screening a Xenopus gastrula cDNA library (Blumberg et al.,
1991) and the nucleotide sequence was determined by the dideoxy
termination method (Sanger et al., 1977). The isolated cDNA en-MATERIALS AND METHODS
codes a protein of 507 amino acids that is 99% identical to XAR3
(Kondo et al., 1996). The sequence we isolated was deposited in
Embryo Manipulations GenBank (U49914). An activated form of the receptor was con-
structed by introducing a Gln 205 to Asp mutation using the Cha-
Xenopus females were induced to ovulate by injection of 800 meleon site-directed mutagenesis kit (Stratagene). The oligonucleo-
units of human chorionic gonadotropin. Eggs were obtained by arti- tide used for mutagenesis was 5*-AAC AGT TGC TCG GGA TAT
®cial fertilization and dejellied with 3% cysteine (pH 8.0). Embryos TAC TCT AGC AG-3*.
were cultured in 0.11 MMR and staged according to Nieuwkoop
and Faber (1967). For microinjection, embryos were transferred into
0.51 MMR containing 3.5% Ficoll and left for several hours after Activin±BMP Fusion Proteins
injection before the medium was replaced with 0.11 MMR. RNAs
were synthesized from linearized templates using the mMessage Construction of activin-BMP fusion expression plasmids was car-
ried out by Paul Wilson and Ali Hemmati-Brivanlou (RockefellermMachine in vitro transcription kit (Ambion). Epidermal induction
assays using dissociated Xenopus ectoderm were adapted from the University). In order to construct activin/BMP fusion genes, the
mature region of Xenopus BMP genes (Nishimatsu et al., 1992) wasmethod of Wilson and Hemmati-Brivanlou (1995). Brie¯y, animal
caps were excised from late blastula embryos in 11CMFM (Sargent ampli®ed by PCR using three different sets of oligonucleotides.
The oligonucleotide sequences are as follows: Activin-BMP2 (AB2),et al., 1986) and transferred into 11 CMFB (Wilson and Hemmati-
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5*-CGC TCG AGC ACA AAC AAC GTA AAC G-3* and 5*-CGA 2-cell stage embryos dorsalized embryos (27 of 47 embryos
GAT CTC TAA CGG CAT CCG CAC CC-3*. Activin-BMP4 (AB4), injected; 57%, data not shown) and induced secondary axis
5*-CGC TCG AGA GTC CAA AAC AGC AGA GA-3* and 5*-CGA structures in some of them (Fig. 1B; dnBMP2). Dorsalization
GAT CTT CAA CGG CAC CCA CAC CC-3*. Activin-BMP7 (AB7), by dnBMP2 is quite similar to that obtained by injection of
5*-CGC TCG AGA AGC AAG CTT GCA AGA AA-3* and 5*-CGA a dominant negative BMP receptor (Graff et al., 1994; Su-
GAT CTT CAA TGG CAA CCA CAG GC-3*.
zuki et al., 1994; Maeno et al., 1994). The opposing effectsThe ampli®ed products were digested by XhoI and BglII and
of dnBMP2 and wild-type BMP2 suggested that the changessubcloned in-frame into the XhoI/BglII sites of pSP64T-activin/
in dnBMP2 not only block its biological activity but alsoVg1 cDNA (Kessler and Melton, 1995). All Vg1 sequence was
act in a dominant negative fashion on an endogenous ligandeliminated. The AB2, AB4, and AB7 chimeras contain the activin
propeptide, the tetrabasic cleavage site, and the ®rst three amino in Xenopus embryos. Supporting this, co-injection of
acids of the activin mature region. This segment is followed by dnBMP2 with wild-type BMP2 rescues axial structures and
mature peptides of BMP2, BMP4, and BMP7 starting from the head structures including eyes and cement gland (Fig. 1B;
10th, 13th, and 3rd amino acids before the ®rst cysteine residue, dnBMP2 / WTBMP2). In animal cap assays, dnBMP2 can
respectively. RNAs synthesized from these constructs and inhibit a-globin mRNA induction by wild-type BMP2 if a
pSP64T-activinbB (Thomsen et al., 1990) were injected into man- 12.5-fold molar excess of dnBMP2 was injected (Fig. 1C,
ually dissected Xenopus oocytes. After injection, oocytes were
lane 5).cultured in 11MBS (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3,
The speci®cation of epidermal fate in the ectoderm has0.41 mM CaCl2 , 0.33 mM Ca(NO3)2 , 0.82 mM MgSO4, 10 mM
been suggested to be under the control of BMP-type factorsHepes, pH7.4) containing 0.5 mg/ml BSA and [35S]methionine for
(Wilson and Hemmati-Brivanlou, 1995). If BMP2 has an in-3 days. The level of protein were com®rmed by loading of the
oocyte conditioned medium on a 15% SDS±polyacrylamide gel structive role in epidermal formation during gastrulation,
following autoradiography. The culture media were assayed for inhibition of BMP2 signaling would cause the neuralization
epidermal induction as described above except for adding 2 mM of ectoderm that would otherwise form epidermis. Figure 2
EDTA into the 11 CMFB solution during dissociation. shows the effect of dnBMP2 on the fate of ectoderm in an
animal cap assay. Animal caps were isolated from embryos
injected with 2.0 ng of the dnBMP2 RNA and cultured untilRT±PCR Analysis
sibling embryos reached early gastrula (lanes 1±5) and tad-
RNA was puri®ed using the acid guanidinium thiocyanate±phe- pole stages (lanes 6±10). Animal caps injected with dnBMP2
nol±chloroform method (Chomczynski and Sacchi, 1987). Reverse RNA expressed the neural-speci®c marker NCAM and the
transcription±PCR (RT±PCR) was carried out as described pre- cement gland marker XAG1 (lane 9), displaying a phenotype
viously (Wilson and Hemmati-Brivanlou, 1995). Sequence of prim- similar to the neuralization induced by a dominant negative
ers used are described in Wilson and Hemmati-Brivanlou (1995) BMP receptor, tBR (Sasai et al., 1995; Suzuki et al., 1995;
and Suzuki et al. (1995, 1997a).
Xu et al., 1995). Neuralization by dnBMP2 is direct: the
animal caps do not express the general mesoderm marker
brachyury, Xbra, at early gastrula stages (lane 4). These re-RESULTS
sults, together with the observation that the BMP2 gene is
expressed during early development (Suzuki et al., 1993;Disruption of BMP2 Signaling Causes Clement et al., 1995; Hemmati-Brivanlou and Thomsen,Neuralization of Ectoderm 1995), indicate that embryonic BMP2 may be involved in
epidermal induction of Xenopus ectoderm.To examine whether BMP2 is involved in epidermal in-
duction, we designed a dominant negative mutant of BMP2
(dnBMP2), obtained by changing the required basic amino
The Xenopus ALK2 Receptor Transduces BMP-likeacids in the proteolytic processing site from ``RQKR'' to
Signals``GQQG'' (Fig. 1A). These basic amino acids are essential
for processing: similar mutants of BMP4 and BMP7 suppress Receptors for the TGF-b family consist of two different
transmembrane Ser/Thr kinases, called type I and type IIthe function of BMP in embryos by inhibiting the processing
of the endogenous propeptides when overexpressed (Hawley receptors. Ligand binding causes the association of the type
I and type II receptors. This association phosphorylates theet al., 1995). This result suggested that dnBMP2 would act
similarly to inhibit processing of cognate ligands in em- type I receptor which then activates downstream effectors
(MassagueÂ , 1996). A type I receptor which binds BMP7 (OP-bryos. The ability of dnBMP2 to inhibit the activity of wild-
type BMP2 (WTBMP2) was tested by injecting mRNA en- 1) and activin has been identi®ed in humans and has been
named activin receptor-like kinase 2 (hALK2) (Attisano etcoding both BMP2 and dnBMP2 into the embryo (Fig. 1B)
and analyzing the expression of markers in animal caps by al., 1993; ten Dijke et al., 1994a, b). Interestingly, this recep-
tor does not bind BMP4, a strong candidate for an endoge-RT±PCR (Fig. 1C). Injected BMP2 RNA ventralizes embryos
(Fig. 1B) and strongly induces the ventral mesoderm marker nous epidermal inducer (ten Dijke et al., 1994b). hALK2
also has been shown to bind BMP2 in addition to BMP7 anda-globin (Fig. 1C, lane 4), as previously demonstrated
(Clement et al., 1995; Hemmati-Brivanlou and Thomsen, transduce their signals in combination with the BMP type
II receptor (Liu et al., 1995). Therefore, hALK2 may act as an1995). However, injection of 2.0 ng of dnBMP2 mRNA into
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FIG. 1. Dominant negative BMP2 ligand inhibits BMP2 function in Xenopus embryos. (A) Structure of dominant negative BMP2 ligand
(dnBMP2). Mutations were introduced in the proteolytic processing site of the Xenopus BMP2 gene changing the amino acid sequence
from ``RQKR'' to ``GQQG'' and disrupting the basic core required for activating the ligand by processing. Hatched and black boxes indicate
pro and mature peptides of the BMP2 protein, respectively. (B) dnBMP2 induces a secondary axis and reverts ventralization of embryos
injected with wild-type BMP2. Synthetic RNAs were injected into Xenopus embryos at the 2-cell stage and developed to tailbud stage.
Amounts of RNAs are indicated. Note that a 12.5-fold excess of dnBMP2 RNA rescues head and dorsal axis structures in ventralized
embryos induced by the injection of 0.2 ng of wild-type BMP2 RNA. (C) dnBMP2 inhibits ventral mesoderm induction by wild-type BMP2.
Embryos were injected with wild-type BMP2 RNA alone (0.2 ng) or with both wild-type BMP2 (0.2 ng) and dnBMP2 (2.5 ng) RNA. RNA
was injected into the animal pole of 2-cell embryos, and animal caps were excised at blastula stage. The isolated caps were cultured in
0.51 MMR until stage 30 and subjected to RT±PCR analysis. EF1-a was used as a loading control and absence of reverse transcriptase in
the RT±PCR reaction is shown as 0RT.
activin and BMP2/7 type I receptor. We isolated a Xenopus It has been reported that a single amino acid substitution
in the GS domain, a 30-amino-acid region preceding thehomolog of human ALK2 (XALK2) from a Xenopus gastrula
cDNA library. This cDNA encodes a protein of 507 amino kinase domain of type I receptors, can activate the receptor
in the absence of ligand or type II receptor (Wieser et al.,acids that shares 82% identity overall with hALK2 and 94%
similar in the kinase domain. This suggests that XALK2 1995). On the basis of this observation, we designed a simi-
larly activated XALK2 to examine the signaling evoked bymight transmit signals closely related to that of hALK2.
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FIG. 2. dnBMP2 can induce neural tissue in ectoderm. Animal caps derived from embryos injected with 2.0 ng of dnBMP2 or a truncated
BMP receptor (tBR) RNA at the 2-cell stage were cultured and subjected to RT±PCR analysis at early (stage 11.5) and late (stage 30)
developmental stages. Xbra, NCAM, and XAG1 were used as markers of general mesoderm, neural tissue, and cement gland, respectively.
EF1-a was used as loading control for each stage. Inhibition of BMP2 signaling in ectoderm induces neural tissue and cement gland just
like tBR and neither induces mesoderm.
this receptor. As shown in Fig. 3A, a glutamine at amino position 205 transmits a BMP-like ventralizing signal in
Xenopus embryos. Thus, although ALK2 seems to bind ac-acid position 205 of the XALK2 receptor was replaced by
an aspartic acid to generate the activated form of the recep- tivins (Attisano et al., 1993; ten Dijke et al., 1994a) as well
as BMP 2 and 7 (Liu et al., 1995; ten Dijke et al., 1994b),tor. Expression of constitutively activated XALK2 (CA-
XALK2; lane 3) in animal caps induced a variety of ventral in the context of the Xenopus embryo, it seems to transduce
only a BMP type of signal.mesoderm markers such as Xbra, Xhox3, XWnt-8, and a-
globin, while wild-type XALK2 (WT-XALK2; lane 2) did not
induce any markers (Fig. 3B). Dorsal mesodermal markers
Constitutive Activation of the XALK2 Receptorlike goosecoid (Gsc) and cardiac actin were not induced by
Promotes Epidermal Inductioneither WT-XALK2 or CA-XALK2 injections. Injection of 2.0
ng of WT-XALK2 RNA led to a reduction in the size of the BMP4 protein has been shown to induce epidermis and
inhibit formation of neural tissue in dissociated late blas-head and anterior structures such as the eyes (in 61% of
cases, n  33), while the expression of the same amount tula ectoderm cells (Wilson and Hemmati-Brivanlou, 1995).
Figure 4 demonstrates that expression of an activatedof CA-XALK2 produced embryos lacking heads and axial
mesoderm (in more than 90% of cases, n  44; Fig. 3C). XALK2 receptor induces epidermis over the default neural
state in dissociated Xenopus ectoderm. Dissociation of ecto-Expression of the neural marker NCAM and the dorsal
mesoderm marker cardiac actin was reduced in whole em- derm cells for 5 hr followed by reaggregation results in the
formation of neural tissue and suppresses the expression ofbryos, consistent with the ventralized phenotype generated
by the CA-XALK2 receptor (data not shown). The partial epidermal keratin at midneurula stage (stage 18; Fig. 4, lane
4). As previously demonstrated BMP4 can induce epidermisventralization by WT-XALK2 could be due to spontaneous
activation of the WT-XALK2 receptor. Assuming that over- in dissociated explants (lane 5). Dissociated ectoderm cells
injected with 0.2 ng or 2.0 ng of WT-XALK2 failed to expressexpression of WT-XALK2 forces receptor complex forma-
tion between XALK2 and the endogenous type II receptors, epidermal markers and were not completely prevented from
forming neural tissue (lanes 6 and 7). However, the samethis interaction may occasionally induce the activation of
XALK2 and lead to ventralization. The phenotype observed dose of CA-XALK2 strongly induced the expression of epi-
dermal keratin and inhibited NCAM expression (lanes 8in embryos injected with the CA-XALK2 receptor is similar
to the one produced by the overexpression of BMP genes, and 9). This inhibition of neural, and induction of epider-
mal, fate occurs while the cells are still ectodermal, as theindicating that the receptor with a Gln to Asp mutation at
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FIG. 3. Activated XALK2 receptor mimics BMP-like signals. (A) Structure of activated BMP2/7 receptor, XALK2. A Xenopus homologue
of the human XALK2 receptor (hALK2), XALK2, was isolated from a Xenopus gastrula library as described under Materials and Methods.
Twenty-eight of 30 amino acids in the GS domain of these receptors were identical (shown as dots). A point mutation was introduced to
change the glutamine (Q) at amino acid position 205 to aspartic acid (D). The position of the mutation is indicated by a box and amino
acid numbers are shown. The XALK2 receptor subdomains are represented as follows: vertical bars, extracellular domain; black box,
transmembrane domain; gray box, GS box; hatched box, kinase domain. Wild-type and mutant XALK2 receptors are indicated as WT-
XALK2 and CA-XALK2, respectively. (B) An activated XALK2 receptor induces ventral mesoderm in animal caps. Animal caps injected
with synthetic RNAs were cultured until sibling control embryos reached gastrula (stage 11) or tailbud (stage 27) stages. RT±PCR analysis
was done using primers speci®c for dorsal and ventral markers. Histone H4 was used as a loading control for each stage. Constitutive
active XALK2 receptor (CA-XALK2; lane 3), but not wild-type XALK2 receptor (WT-XALK2; lane 2), induced variety of ventral mesoderm
markers including the blood marker a-globin. Animal caps injected with b-globin RNA was used as an injection control (lane 1). (C)
Overexpression of wild-type and activated XALK2 receptors affects dorsal axis formation of Xenopus embryos. Embryos were injected
with 2.0 ng of RNAs at the 2-cell stage and developed to stage 35. RNA used for each injection is as follows: top embryo, b-globin as
control; middle embryo, wild-type XALK2; bottom embryo, activated XALK2.
mesodermal marker Xbra is not induced. The low-level ex- 1997a; Wilson et al., 1997). These results suggest that the
activated XALK2 receptor can promote epidermal fate inpression of NCAM in dissociated cells injected with WT-
XALK2 RNA can be interpreted as a weak inhibition of Xenopus ectoderm.
neural tissue formation. As shown in Fig. 3C, overex-
Mature BMP2 and BMP7 Proteins Inducepression of wild-type XALK2 has a weak ventralizing activ-
Epidermis in Dissociated Xenopusity. In addition, we have observed that low doses of BMP4 or
Ectodermal Cellsoverexpression of its signal transducers, Smad1 and Smad5,
result in reduced expression of NCAM with almost no epi- Finally, we examined the epidermal inducing activity of
BMP2 and BMP7 proteins. A chimeric activin±Vg1 mRNAdermal keratin expression in dissociated cells (Suzuki et al.,
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to mature AB2, AB4, or AB7 proteins express epidermal kera-
tin and suppress the neural marker NCAM (lanes 5±7). The
epidermal induction observed with AB7 treatment is rather
weak compared to that observed in AB2 or AB4 treatments.
Similar results are obtained when explants were injected
with RNAs encoding wild-type Xenopus BMP2, BMP4, or
BMP7 prior to dissociation (data not shown). In agreement
with previous observations, activin also inhibits neural in-
duction but does not induce epidermis (Wilson and Hem-
mati-Brivanlou, 1995). The inhibition of NCAM by activin
can be attributed to mesoderm induction, since the mesoder-
mal marker Xbra is induced (lane 8). Mesoderm induction is
never observed in cells treated with the mature BMP proteins
(lanes 5±7), suggesting that these BMP proteins can directly
induce epidermis from ectoderm. This is in agreement with
observations made with both the dominant negative BMP2
ligand and the activated BMP2/7 receptor. We have also ob-
tained epidermal inducing activity using wild-type recombi-
nant Xenopus BMP2, which was overproduced by transfec-
tion of mammalian cells (data not shown).
DISCUSSION
FIG. 4. An activated XALK2 receptor induces epidermis. Wild-
type or activated XALK2 receptors were injected into the animal In this paper, we describe the involvement of BMP2 and
pole of 2-cell stage embryos and animal caps were excised at the BMP7 in epidermal induction during Xenopus development.
blastula stage. Dissociated ectoderm cells were prepared as de-
We ®nd that a dominant negative BMP2 ligand can inducescribed under Materials and Methods and kept dissociated for 5 hr
neural tissue in the ectoderm, at the expense of epidermis.followed by reaggregation in a medium containing calcium and
We also show that an activated XALK2 receptor, whichmagnesium. Recombinant human BMP4 was used as a control at
binds BMP2 and BMP7, promotes epidermal induction ina concentration of 50 ng/ml (lane 5). Constitutively active XALK2
(CA-XALK2; lanes 8 and 9), but not wild-type XALK2 (WT-XALK2; dissociated ectoderm which would otherwise form neural
lanes 6 and 7), can induce epidermal keratin. A general mesoderm tissue. Moreover, secreted Xenopus BMP2 and BMP7 pro-
maker, Xbra, was not detected in any sample. teins can direct epidermal fate in these assays. Based on
these results and the arguments presented below, we sug-
gest that, in addition to BMP4, BMP2, and BMP7 also act
as endogenous epidermal inducers.
encoding the pro-region of activin fused to the mature re-
gion of Vg1 has been shown to result in the processing and
Epidermal Induction by BMPssecretion of mature Vg1 protein when the mRNA is injected
into Xenopus oocytes (Kessler and Melton, 1995). In order Our results and previous reports suggest that multiple
BMP ligands are involved in the induction of epidermis into produce mature BMP proteins, we made activin±BMP
fusion constructs that are similar to the activin±Vg1 chi- ectoderm (Wilson and Hemmati-Brivanlou, 1995; Hawley
et al., 1995). This leads to the question of whether differentmera (Fig. 5A). Injection of the mRNAs encoding activin±
BMP fusion proteins results in the secretion of the BMP BMPs induce epidermis through different pathways. As
mentioned above, TGF-b ligands bind to two types of mem-proteins (Fig. 5B). The molecular weights of the proteins
range from 14 to 25 kDa under reducing conditions (lanes brane receptors (type I and type II); activation of the type I
receptor by the type II receptor is required for signaling. At3±5) and the appearance of multiple bands may be due to
glycosylation (Aono et al., 1995). As mature BMP2 (AB2), least three different BMP type I receptors (ALK2, ALK3, and
ALK6) and a type II receptor (BMPRII) have been identi®edBMP4 (AB4), and BMP7 (AB7) have two methionine residues
in the secreted mature domain, the intensity of bands on in vertebrates, and ALK3, ALK6, and BMPRII bind all three
BMPs (Liu et al., 1995; ten Dijke et al., 1994b; Yamashita etthe autoradiogram should directly re¯ect the amount of
BMP protein. Therefore, we conclude that the levels of the al., 1995). It is thus conceivable that the epidermal inducing
pathway of BMP2 and BMP7 overlaps that of BMP4 at thesecreted BMPs are comparable (Fig. 5B, lanes 3±5). The con-
ditioned media from injected oocytes were applied to dissoci- receptor level. ALK2 binds BMP2 and BMP7, but not BMP4
(ten Dijke et al., 1994b), and overexpression of activatedated ectoderm cells isolated from Xenopus blastulae and in-
duction of epidermal keratin expression was analyzed by ALK2 mimics BMP-like activities (Figs. 3 and 4). If activa-
tion of ALK2 simply translates to the activation of BMP2RT±PCR. Figure 5C shows that the dissociated cells exposed
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and BMP7 signaling pathways, the results obtained by acti-
vated ALK2 suggest that BMP2 and BMP7 may use a differ-
ent pathway than BMP4. However, it is possible that activa-
tion of ALK2 is also involved in BMP4 signaling through
interaction with other related receptors. Ligand binding of
TGF-bs induces a hetero-oligomeric receptor complex com-
posed of two pairs of type I and type II receptors (Yamashita
et al., 1994; MassagueÂ , 1996). While hetero-oligomer forma-
tion of BMP receptors is still under investigation, it is possi-
ble that binding of BMP4 to ALK3 or ALK6 might induce
formation of a receptor complex containing ALK2, and lead
to activation of ALK2. Thus, ALK2 might act in BMP4 sig-
naling, as well.
Additionally, it could be argued that epidermal induction
by BMP2 and BMP7 could be mediated through a heterodim-
erization with BMP4 ligand. There is evidence from bone
induction assays that heterodimers of two different BMPs
are more potent than homodimers of each. For example,
BMP4/7 heterodimers have a much higher activity in the
induction of alkaline phosphatase from MC3T3-E1 cells and
ectopic bone induction than homodimers of either ligand
(Aono et al., 1995; Hazama et al., 1995). There is also evi-
dence that this same heterodimer induces mesoderm in
physiological doses in the intact animal cap, while BMP4
and BMP7 homodimers do not display this activity (Suzuki
et al., 1997b). In fact, we have observed that overexpression
of dominant negative BMP2 ligand inhibits not only BMP2
but also BMP4 signaling (data not shown). This indicates
that BMP2 and BMP4 may act together in ectoderm, perhaps
as a heterodimer. However, homodimers of BMP2 and
BMP7 are capable of inducing epidermis in dissociated ecto-
derm cells (Fig. 5). Taken together, we conclude that BMP2
and BMP7 may induce epidermis independently or together
with BMP4.
Action of Dominant Negative Ligands and
Receptors on Epidermal Induction by BMPs
Since our results suggest that multiple BMP ligands are
involved in epidermal induction, inhibition of one of the
BMP ligands should not induce neural tissue in ectoderm.
However, expression of a single type I dominant negative
BMP receptor (tBR) or a single BMP dominant negative li-
gand is capable of inducing neural tissue in ectoderm (Sasai
FIG. 5. Mature BMP2 and BMP7 proteins induce epidermis. (A)
Structure of activin±BMP fusion proteins. Activin±BMP fusion were cultured in medium containing [35S]methionine and condi-
constructs were made by PCR: the activin peptide, including the tioned media were collected 3 days after injection. The secreted
processing site, and the three ®rst amino acids of the mature region proteins were analyzed on a 15% polyacrylamide gel under reducing
were fused in-frame to amino termini of BMP mature domains. conditions and followed by autoradiography. (C) The conditioned
Activin and BMP amino acid sequences are represented as black media were diluted 12.5-fold with 11 CMFB supplemented with 2
and gray, respectively. The processing sites of activin and BMP mM EDTA and used in dissociated ectoderm cell assays. After cul-
are also indicated as hatched and white boxes, respectively. (B) turing the dissociated cells in the medium containing the condi-
Production of secreted BMPs in Xenopus oocytes. RNAs encoding tioned media for 5 hr, ectoderm cells were reaggregated and cultured
activin±BMP2 (AB2), activin±BMP4 (AB4), activin±BMP7 (AB7), until control embryos developed to neurula stage (stage 18). Condi-
and activin protein were injected into Xenopus oocytes. Oocytes tioned medium from uninjected oocytes was used as a control.
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et al., 1995; Suzuki et al., 1995; Xu et al., 1995; Hawley et sion of a neural crest marker, slug (Mayor et al., 1995), and
noggin shows higher af®nity for BMP4 than BMP7 (Zimmer-al., 1995; this study). How do the tBR or dominant negative
ligands induce neural tissue in ectoderm if epidermal induc- man et al., 1996). It is also possible that if noggin and
chordin bind to different sites on the BMP molecules, modi-tion is mediated by multiple BMP ligands? Neural induction
by tBR could be attributed to the broad ligand binding capac- ®cation of BMP activities might be more complex through
the cooperation of these neural inducing factors. Thus,ity of this receptor which binds all three BMP ligands (Graff
et al., 1994; Suzuki et al., 1994; ten Dijke et al., 1994b). through the interaction of the BMPs and their inhibitors, a
number of different ectodermally derived tissues might beFormation of heteromeric complexes of type I and type II
receptors also may account for neural induction by tBR. tBR induced.
was obtained by deleting the intracellular domain of the
receptor and retains a transmembrane domain which might
Mesoderm Induction via BMP Receptorsbe involved in receptor±receptor association in the plasma
membrane. Although tBR does not inhibit signaling of dis- ALK2 has been characterized as a type I receptor for ac-
tivin, BMP2, and BMP7 (Attisano et al., 1993; Liu et al.,tantly related TGF-b family ligands such as activin
(Schmidt et al., 1995), one can speculate that tBR also antag- 1995; ten Dijke et al., 1994a, 1994b). We have shown that
signals mediated through the XALK2 receptor induce ven-onizes multiple BMP ligands by disrupting functional hete-
ro- or homo-oligomeric complexes of type I and type II re- tral mesoderm in animal caps and ventralize intact em-
bryos. Thus, while the XALK2 has an af®nity for multipleceptors. In case of the dominant negative BMP ligands, all
of the mutant ligands including BMP2, BMP4, and BMP7 ligands in in vitro binding assays, our results indicate that
the XALK2 receptor acts as a BMP receptor in Xenopuscan inhibit signaling by multiple BMPs (Hawley et al., 1995;
this study). As both dimerization and processing of BMPs embryos. In dissociation/reaggregation assays of ectoderm,
activation of the XALK2 receptor strongly promotes epider-are required for their biological activities, the inhibitory
BMP ligands may affect these processes by forming hetero- mal fate without induction of mesoderm. The fact that acti-
vated XALK2 can induce mesoderm in animal caps but notdimers with endogenous BMP ligands. It is also possible
that dimers of the inhibitory BMP ligands may mask ligand in dissociated cells emphasizes that mesoderm induction by
BMP-related factors may require secondary communicationbinding sites on the BMP receptors. Either mechanism
could inhibit a broad range of BMP signaling and lead to between ectoderm cells during gastrulation. This is sup-
ported by the observation that induction of the ventralthe neuralization of the ectoderm. It is clear that further
biochemical characterization of ligand±receptor interac- mesoderm marker a-globin by Smad1, a downstream ef-
fector of BMP receptor signaling, can be inhibited by inter-tions are required to elucidate not only the action of domi-
nant negative ligands and receptors, but also the role of rupting endogenous BMP signals (Graff et al., 1994). In addi-
tion, ventral mesoderm induction in intact caps by CA-independent BMP ligands in the patterning of the embryo.
XALK2 suggests that BMPs might be involved not only in
the patterning, but also the induction of mesoderm. It will
Negative Regulation of BMP Activities by Neural be of interest to determine which BMP receptors are em-
Inducing Factors ployed by the various BMPs and which direct the speci®ca-
tion of ventral mesoderm or epidermis, respectively.In Xenopus embryos, neural tissue arises from ectodermal
cells in response to signals emanating from the organizer
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